Danish company Novo Nordisk has agreed to acquire ocedurenone—a drug in development for uncontrolled hypertension with potential application in cardiovascular a 16 October 2023
Dutch biosynthetic pharma products specialist Centrient Pharmaceuticals is to open its new innovation lab at Spanish dermatology company Almirall’s R&D center i 10 October 2023
Information from research group GlobalData suggests there is a pressing need for innovation and collaboration in China to address an unmet medical need in Fabry 29 September 2023
Danish company Acesion Pharma has closed an oversubscribed series B financing round, raising around $48 million to support its work in atrial fibrillation (AF). 26 September 2023
Danish drugmaker Novo Nordisk and Valo Health have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases. 25 September 2023
Swiss pharma firm Acino has acquired M8 Pharmaceuticals, a specialty biopharmaceutical company focused on licensing, marketing, and distributing innovative and 20 September 2023
With medical research into molecular glues on the rise, research from Harvard University is finding its way into the local biotech scene. 19 September 2023
A novel antibody developed by Anthos Therapeutics, a cardiovascular specialist founded by Blackstone Life Sciences, has performed well in a Phase II trial. 18 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.